Company performance
Add to research
Current Price
as of Mar 20, 2025$3.95
P/E Ratio
N/A
Market Cap
$2.18M
Description
Add to research
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
Metrics
Add to research
Overview
- HQActon, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerBJDX
- Price$3.95-3.66%
Trading Information
- Market cap$2.18M
- Float99.71%
- Average Daily Volume (1m)66,734
- Average Daily Volume (3m)87,276
- EPS-$1,402.01
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$1.48M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$1.31M
- EV-$4.29M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.20
- Debt/Equity3.57
Documents
Add to research
SEC Filings
Factset Street Account
Factset